The FORTIS transcatheter mitral valve (Edwards Lifesciences, Irvine, CA, USA) is a self-expanding device implanted via a transapical approach that is currently undergoing first-in-man trials. Below is a link to the paper with the latest evidence on the device and a link to the news release.
Bapat et al. 2014 Eurointervention
